| __timestamp | BioMarin Pharmaceutical Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 302156000 | 2999000 |
| Thursday, January 1, 2015 | 402271000 | 10393000 |
| Friday, January 1, 2016 | 476593000 | 15994000 |
| Sunday, January 1, 2017 | 554336000 | 26975000 |
| Monday, January 1, 2018 | 604353000 | 39509000 |
| Tuesday, January 1, 2019 | 680924000 | 48869000 |
| Wednesday, January 1, 2020 | 737669000 | 42510000 |
| Friday, January 1, 2021 | 759375000 | 46105000 |
| Saturday, January 1, 2022 | 854009000 | 50513000 |
| Sunday, January 1, 2023 | 937300000 | 51292000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing costs is crucial for success. BioMarin Pharmaceutical Inc. and Wave Life Sciences Ltd. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, BioMarin's SG&A expenses surged by over 200%, reflecting its aggressive growth strategy and expansion efforts. In contrast, Wave Life Sciences saw a more modest increase of around 1,600%, albeit from a much smaller base, highlighting its cautious yet steady approach.
BioMarin's expenses consistently outpaced Wave's, peaking at nearly 19 times higher in 2023. This disparity underscores the different scales and operational strategies of these two companies. As the biotech industry continues to evolve, understanding these financial dynamics provides valuable insights into the strategic priorities and market positioning of leading firms.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs BioMarin Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Novartis AG and Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Sanofi vs BioMarin Pharmaceutical Inc.
Sanofi or Wave Life Sciences Ltd.: Who Manages SG&A Costs Better?
BioMarin Pharmaceutical Inc. or Ionis Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Veracyte, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Bausch Health Companies Inc.
Catalent, Inc. vs Wave Life Sciences Ltd.: SG&A Expense Trends
Jazz Pharmaceuticals plc and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: TG Therapeutics, Inc. vs Wave Life Sciences Ltd.
SG&A Efficiency Analysis: Comparing Wave Life Sciences Ltd. and BioCryst Pharmaceuticals, Inc.
Wave Life Sciences Ltd. vs Evotec SE: SG&A Expense Trends